Back to search

Article

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer

2024-10-10

Abstract excerpt

Ovarian cancer has the highest mortality of all gynecological cancers and in symptomatic women, surgery is commonly used as final diagnostic. Available literature indicates that women with benign tumors could often be conservatively managed but accurate molecular tests are needed for triaging where gold-standard imaging techniques are inconclusive or lacking. Here, we analyzed 5416 plasma proteins in two independe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e09074e6-69f2-501a-9f9f-ac02d87c13e5
DOI
10.1101/2024.10.10.24315232
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancerDOI 10.1101/2024.10.10.24315232
Select a neighboring publication to make it the new centre.